(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÕES DE ANTICORPOS ANTI-PD-L1 HUMANOS

ArquivadaInvention PatentPCT · EP2019060498

Application data

Number

112020020390

Type

Invention Patent

Filing

04/24/2019

Publication

01/19/2021

PCT

EP2019060498

Progress at the INPI

  1. Filing04/24/19
  2. Publication01/19/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/14/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MEDIMMUNE LIMITED

GB

See this company's full portfolio

Inventors

J. B. (pessoa física)

GB

J. M. (pessoa física)

GB

J. D. (pessoa física)

GB

M. A. (pessoa física)

GB

Technical data

IPC Classification

Priority claims

US

62/662,324 · 04/25/2018

Abstract

A presente descrição se refere a formulações e composições de um anticorpo dirigido contra anti-PD-L1 humano, tal como durvalumabe.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

04/14/2026

RPI 2884

Parecer de pré-exame

#6.23

01/06/2026

RPI 2870

Adição na publicação

#15.35

12/14/2021

RPI 2658

Notificação de entrada na fase nacional - PCT

#1.3

01/19/2021

RPI 2611

Alteração de dados cadastrais

#1.1

10/27/2020

RPI 2599

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.